| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |